An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
复制标题
DOI：
10.1111/1744-9987.12378
复制
发表时间：
2015-12-01
影响因子：
1.9
通讯作者：
Nitta, Kosaku
中科院分区：
文献类型：
--
作者：
Masakane, Ikuto;Nakai, Shigeru;Nitta, Kosaku
2013年底，对4325家透析机构进行了全国性调查，其中4268家（98.7%）做出了答复。2013年，新透析患者人数为38，095人。自2008年以来，新透析患者的数量几乎保持不变，没有明显增加或减少。2013年透析患者死亡人数为30751人。日本的透析患者人数每年都在增长; 2013年底为314，438人。2013年底，每百万透析患者人数为2470人。2013年透析患者的粗死亡率为9.8%。新透析患者的平均年龄为68.7岁，整个透析患者人群的平均年龄为67.2岁。新透析患者中最常见的肾衰竭主要原因是糖尿病肾病（43.8%）。糖尿病肾病的新透析患者的实际数量在过去几年几乎没有变化。糖尿病肾病也是整个透析患者人群中最常见的原发病（37.6%），其次是慢性肾小球肾炎（32.4%）。糖尿病肾病透析患者的比例不断增加，而慢性肾小球肾炎透析患者的比例则不断下降。2013年底接受血液透析滤过（HDF）的患者人数为31 371人，较2012年显著增加。这一数字是2011年底的两倍多，大约是2012年底的1.5倍。特别是，在过去2年中，接受在线HDF的患者数量增加了约5倍。在151426例透析患者中，除糖尿病肾病外，10.8%的患者有糖尿病病史。在有糖尿病史的患者中，26.8%的患者使用糖蛋白作为血糖水平的指标;分别有33.0%和27.6%的患者使用胰岛素和二肽基肽酶（DPP）-4抑制剂作为糖尿病药物。机构调查显示，9392例患者接受腹膜透析（PD）。患者调查显示，这些PD患者中有1920例还接受了另一种使用体外循环的透析方法，如血液透析（HD）或HDF。截至2013年年底，在家中接受血液透析治疗的患者人数为461人，较2012年年底的393人显著增加。
A nationwide survey of 4325 dialysis facilities was conducted at the end of 2013, among which 4268 (98.7%) responded. The number of new dialysis patients was 38 095 in 2013. Since 2008, the number of new dialysis patients has remained almost the same without any marked increase or decrease. The number of dialysis patients who died in 2013 was 30 751. The dialysis patient population has been growing every year in Japan; it was 314 438 at the end of 2013. The number of dialysis patients per million at the end of 2013 was 2470. The crude death rate of dialysis patients in 2013 was 9.8%. The mean age of new dialysis patients was 68.7 years and the mean age of the entire dialysis patient population was 67.2 years. The most common primary cause of renal failure among new dialysis patients was diabetic nephropathy (43.8%). The actual number of new dialysis patients with diabetic nephropathy has almost been unchanged for the last few years. Diabetic nephropathy was also the most common primary disease among the entire dialysis patient population (37.6%), followed by chronic glomerulonephritis (32.4%). The percentage of dialysis patients with diabetic nephropathy has been increasing continuously, whereas the percentage of dialysis patients with chronic glomerulonephritis has been decreasing. The number of patients who underwent hemodiafiltration (HDF) at the end of 2013 was 31 371, a marked increase from that in 2012. This number is more than twice that at the end of 2011 and approximately 1.5 times the number at the end of 2012. In particular, the number of patients who underwent online HDF increased approximately fivefold over the last 2 years. Among 151 426 dialysis patients with primary causes of renal failure other than diabetic nephropathy, 10.8% had a history of diabetes. Among those with a history of diabetes, 26.8% used glycoalbumin as an indicator of blood glucose level; and 33.0 and 27.6% were administered insulin and dipeptidyl peptidase (DPP)-4 inhibitor, respectively, as a medication of diabetes. The facility survey showed that 9392 patients underwent peritoneal dialysis (PD). The patient survey revealed that 1920 of these PD patients also underwent another dialysis method using extracorporeal circulation, such as hemodialysis (HD) or HDF. The number of patients who underwent HD at home at the end of 2013 was 461, a marked increase from that at the end of 2012 (393).